In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
9 weeks 3 days ago
15 weeks 1 day ago
26 weeks 1 day ago
27 weeks 22 hours ago
28 weeks 4 days ago
29 weeks 1 day ago
29 weeks 3 days ago
33 weeks 6 days ago
34 weeks 6 days ago
35 weeks 9 hours ago